SARESA

Welcome to the Brand page for “SARESA”, which is offered here for Pharmaceutical preparations for the treatment of radioimmune diseases, radioimmunetherapeutics; pharmaceutical preparations in the nature of drug antibody and toxin-antibody conjugates for the purpose of removing and fighting toxins in the body; pharmaceutical preparations in the nature of targeted therapeutics for the diagnosis, therapy and/or prevention of human conditions or disease, for use in the treatment of cancer, specifically blood borne cancers and solid tumors;pharmaceutical preparations in the nature of drug delivery agents consisting compounds that facilitate delivery of a wide range of pharmaceuticals comprised of proteins,peptides, peptidomimetics, lipids, carbohydrates, nucleic acids, aptamers, and/or synthetic organic molecules, that selectively bind to any human or bacterial cell, any cell type, any fungus, any virus, any human pathogen, or any component of the above,including fragments and semi-synthetic derivatives;pharmaceutical drug development services; scientific research in the field of pharmaceuticals; medical and scientific research, conducting clinical trials of pharmaceuticals;.

Its status is currently believed to be active. Its class is unavailable. “SARESA” is believed to be currently owned by “MDS Inc.”